AstraZeneca is one of the world’s leading pharmaceutical companies engaged in the discovery, development, manufacture, and marketing of medicines that address some of the world’s most significant healthcare challenges.
Our global scope
AstraZeneca PLC is headquartered in London, UK, and operates three major hubs: in Sodertalje, Sweden; Alderley Park, UK; and Wilmington, Delaware, USA. Collectively, we operate 11 research and development sites around the world, as well as manufacturing facilities in 19 countries. We sell our products in more than 100 countries. With global healthcare sales exceeding $26.47 billion, we have secured leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology, and neuroscience products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global), as well as in the FTSE4GoodIndex.
Our US presence
As a $12.44 billion healthcare business, our US operations employ more than 12,000 people. Based in Wilmington, Delaware, we have research and development and supply facilities in Delaware and Massachusetts, as well as regional sales and business centers throughout the country. Wilmington also serves as the global home for the AstraZeneca neuroscience commercial and research and development areas. Our Boston location houses infection, oncology, and discovery areas.
Our values
We conduct our business in accordance with the following core values:
- Integrity and high ethical standards
- Respect for the individual and diversity
- Openness, honesty, trust, and support for each other
- Leadership by example at all levels
